News and Announcements




Several ongoing Phase I clinical trials are assessing the safety and tolerability of ATM (ataxia-telangiectasia mutated) and ATR (ataxia-telangiectasia and Rad3-Related) inhibitors when administered alone or in combination with existing therapies. ATM and ATR are attractive therapeutic targets...

December 10, 2018   |   Read More

The second data release for the NCI-CPTAC Multi-omics Enabled Sample Mislabeling Correction Challenge has launched!  If you did not participate in sub-challenge 1 (submission 1), you can still participate in sub-challenge 2 (submission 2).

December 10, 2018   |   Read More

The NCI-CPTAC Multi-omics Enabled Sample Mislabeling Correction Challenge sub-challenge 2 closes on December 19 at 07:59:59 UTC. Just two weeks left to submit your compuational algorithms. Remember, if you did not participate in sub-challenge 1, you can still participate in sub-challenge 2.

December 10, 2018   |   Read More

Latest Tweets